Nammi Therapeutics Featured in Los Angeles Business Journal
Nammi Therapeutics was featured in the Los Angeles Business Journal. The article featured an interview with David Stover, President and...
top of page
Search
- Jan 6, 2023
- 1 min
Amgen and BioLabs LA Announce Nammi Therapeutics to Receive the Third Amgen Golden Ticket
Amgen and BioLabs LA at The Lundquist Institute today announced that Nammi Therapeutics has been awarded the third Amgen Golden Ticker in...
- Dec 15, 2022
- 1 min
Nammi Therapeutics Awarded Grant by California Institute for Regenerative Medicine (CIRM)
The governing Board of the California Institute for Regenerative Medicine (CIRM) funded a Phase 3 clinical trial to support the...
- Jun 16, 2022
- 1 min
Nammi Therapeutics Granted FDA Orphan Drug Designation for QXL138AM for the Treatment of Pancreatic
FDA has granted orphan drug designation (OOD) to Nammi Therapeutic's lead program, QXL138AM, for the treatment of Pancreatic Cancer. QXL...
- Jun 13, 2022
- 1 min
Nammi Therapeutics Granted FDA Orphan Drug Designation for QXL138AM for the Treatment of MM
FDA has granted orphan drug designation (OOD) to Nammi Therapeutic's lead program, QXL138AM, for the treatment of multiple myeloma. QXL...
- Apr 9, 2021
- 2 min
Nammi Therapeutics Unveils Two Novel Immunotherapies at AACR Conference
LOS ANGELES, April 9, 2021 /PRNewswire/ -- Nammi Therapeutics, Inc. (Nammi), an LA- based immunotherapy company, announces its first two...
- May 17, 2019
- 4 min
The stories behind your favorite science subjects
Veteran drug developer David Stover decided to start his own firm the day Astellas Pharma Inc. shuttered its Santa Monica-based Agensys...
bottom of page